(Q33336782)

English

Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase II clinical trial from Germany

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase II clinical trial from Germany (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

phase II clinical trial

0 references

0 references

head and neck cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

advanced head and neck cancer

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

based on heuristic

inferred from title

author name string

Bennett CL

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Lane D

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Stinson T

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Glatzel M

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Buntzel J

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Cancer Investigation

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

107-113

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100000145

21 January 2018

An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100000145

21 January 2018

Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100000145

21 January 2018

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100000145

21 January 2018

Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: implications for economic analyses of phase III clinical trials

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100000145

21 January 2018

Economic analysis in phase III clinical cancer trials

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100000145

21 January 2018

Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/0360-3016(94)90562-2

Identifiers

10.1081/CNV-100000145

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33336782&oldid=1655321048"